TScan Therapeutics
identified covid cell targets developing next generation vaccines diagnostics with partners | TScan Therapeutics
Deck Type
IPO
Deck date
July 2021
Slide
42 of 43
Related slides by other companies
Results
May 2023
Search Thousands of Presentations by World Leading Companies